Estrogen receptor negative and progesterone receptor positive breast carcinomas-how frequent are they?

Pathology and Oncology Research

Volumn 17, Issue 3, 2011, Pages 663-668

  Cserni, Gábor ^a   Francz, Monika ^b   Kálmán, Endre ^c   Kelemen, Gyöngyi ^d   Komjáthy, Detre Csaba ^e   Kovács, Ilona ^e   Kulka, Janina ^f   Sarkadi, László ^e   Udvarhelyi, Nóra ^g   Vass, László ^h   Vörös, András ^d  

^a BÁCS KISKUN COUNTY TEACHING HOSPITAL   (Hungary)

^b Josa Andras Teaching Hospital   (Hungary)

^c UNIVERSITY OF PÉCS   (Hungary)

^d UNIVERSITY OF SZEGED   (Hungary)

^e Kenezy Hospital   (Hungary)

^f SEMMELWEIS UNIVERSITY   (Hungary)

^g NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^h Flór Ferenc University   (Hungary)

Author keywords

Breast cancer; Estrogen receptor; Estrogen receptor negative progesterone receptor positive breast cancer; Immunohistochemistry; Progesterone receptor

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; CYTOPLASM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 80052756449     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-011-9366-y     Document Type: Article

References (9)

1. SK Moshin H Weiss T Havinghurst, et al. 2004 Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study Mod Pathol 17 1545 1554 10.1038/modpathol.3800229 (Pubitemid 39627082)
2. G Viale MM Regan E Maiorano, et al. 2008 Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors-International Breast Cancer Study Group J Clin Oncol 26 1404 1410 18349391 10.1200/JCO.2007.10.6393
3. M Nadji C Gomez-Ferenandez P Ganjei-Azar, et al. 2005 Immunohistochemistry of estrogen and progesterone receptors reconsidered: experience with 5, 993 breast cancers Am J Clin Pathol 123 21 27 15762276 10.1309/4WV79N2GHJ3X1841 (Pubitemid 40066168)
4. L De Maeyer E Van Limbergen K De Nys, et al. 2008 Does estrogen receptor-negative/progesterone receptor-positive breast carcinoma exist? J Clin Oncol 26 335 340 18182677 10.1200/JCO.2007.14.8411
5. A Goldhirsch JH Glick RD Gelber, et al. 2005 Meeting highlights: International expert consensus on the primary therapy of early breast cancer 2005 Ann Oncol 16 1569 1583 16148022 10.1093/annonc/mdi326 1:STN:280: DC%2BD2MvpvFKhsA%3D%3D (Pubitemid 41511089)
6. A Rhodes B Jasani 2009 The oestrogen receptor-negative/progesterone receptor-positive breast tumour: a biological entity or a technical artefact? J Clin Pathol 62 95 96 19103868 10.1136/jcp.2008.060723 1:STN:280: DC%2BD1M%2Fgslyrsw%3D%3D
7. EA Rakha ME El-Sayed AR Green, et al. 2007 Biological and clinical characteristics of breast cancer with single hormone receptor-positive phenotype J Clin Oncol 25 4772 4778 17876012 10.1200/JCO.2007.12.2747 (Pubitemid 350086480)
8. MEH Hammond DF Hayes M Dowsett, et al. 2010 American Society of Clinical Oncology / College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer J Clin Oncol 28 2784 2795 20404251 10.1200/JCO.2009.25.6529
9. G Viale MM Regan E Maiorano, et al. 2007 Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98 J Clin Oncol 25 3846 3652 17679725 10.1200/JCO.2007.11.9453 (Pubitemid 47477259)